IP Library Granted Patent US 10,188,856
Granted Patent B1
US 10,188,856 · App. 13/314,119 · Granted Jan 29, 2019

Implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,188,856
App. No.
13/314,119
Granted
Jan 29, 2019
Kind
B1
Abstract

An implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction is provided. A stimulation therapy lead includes helical electrodes configured to conform to an outer diameter of a cervical vagus nerve sheath, and a set of connector pins electrically connected to the helical electrodes. A neurostimulator includes an electrical receptacle into which the connector pins are securely and electrically coupled. The neurostimulator also includes a pulse generator configured to therapeutically stimulate the vagus nerve through the helical electrodes in alternating cycles of stimuli application and stimuli inhibition that are tuned to both efferently activate the heart's intrinsic nervous system and afferently activate the patient's central reflexes by triggering bi-directional action potentials.

Claims (25)

1. A vagus nerve neurostimulator for treating chronic cardiac dysfunction, comprising:

an implantable neurostimulator comprising:

a pair of helical electrodes;

a nerve stimulation therapy lead electrically coupled to the pair of helical electrodes;

a pulse generator configured to deliver electrical therapeutic stimulation comprising a stimulation waveform applied to both of the helical electrodes via the nerve stimulation therapy lead, the stimulation waveform comprising a form that causes propagation of action potentials in both an afferent direction and an efferent direction within neuronal fibers of a cervical vagus nerve; and

a recordable memory within which is stored stimulation parameters configured to define a periodic duty cycle comprising a percentage of time that the pulse generator delivers the electrical therapeutic stimulation,

wherein the periodic duty cycle is between a lower predefined percentage and an upper predefined percentage,

wherein the pulse generator is further configured to operate under the stimulation parameters stored in the recordable memory.

2. A neurostimulator according to claim 1 , wherein the duty cycle falls within the range of 5% to 30%.

3. A neurostimulator according to claim 1 , further comprising:

a recordable memory within which is stored stimulation parameters configured to define the electrical therapeutic stimulation that the pulse generator delivers through one or more of a programmable output current, a programmable signal frequency, a programmable pulse width, a programmable signal ON time, and a programmable signal OFF time,

wherein the pulse generator is further configured to operate under the stimulation parameters stored in the recordable memory.

4. A neurostimulator according to claim 3 , wherein the stimulation parameters comprise the pulse width falling within the range of 100 to 250 μsec, the output current falling within the range of 0.02 to 50 mA, and the signal frequency substantially comprising 20 Hz.

5. A neurostimulator according to claim 3 , wherein the pulse generator is further configured to provide at least one of a ramp-up time during which the output current is progressively increased and a ramp-down time during which the output current is progressively decreased respectively preceding and following therapeutic stimulation at full output current.

6. An implantable device for treating chronic cardiac dysfunction, comprising:

an implantable neurostimulator comprising a pulse generator configured to deliver electrical therapeutic stimulation comprising a stimulation waveform, the stimulation waveform comprising a form that causes propagation of action potentials in both an afferent direction and an efferent direction within neuronal fibers of a cervical vagus nerve; and

a cervical vagus nerve stimulation therapy lead electrically coupled to the pulse generator and terminated by a pair of helical electrodes through which the electrical therapeutic stimulation is delivered to the patient's cervical vagus nerve; and

a recordable memory within which is stored stimulation parameters configured to define a periodic duty cycle for the alternating cycles of stimuli application and stimuli inhibition, which the pulse generator delivers that falls within the range of 5% to 30%,

wherein the pulse generator is further configured to operate under the stimulation parameters stored in the recordable memory.

7. An implantable device according to claim 6 , further comprising:

a recordable memory within which is stored stimulation parameters configured to define the electrical therapeutic stimulation, which the pulse generator delivers through a pulse width falling within the range of 100 to 250 μsec, an output current falling within the range of 0.02 to 50 mA, and a signal frequency substantially comprising 20 Hz.

8. An implantable device according to claim 6 , wherein:

the therapy lead comprises a connector pin and an insulated electrical lead body which are electrically connected to the helical electrodes; and

the implantable neurostimulator further comprises an electrical receptacle positioned on an outer surface of the neurostimulator and the electrical receptacle is configured to receive the connector pin that is securely and electrically connected to the pulse generator.

9. A neurostimulator according to claim 1 , wherein the pulse generator is configured to therapeutically stimulate the patient's cervical vagus nerve through the pair of helical electrodes in alternating cycles of stimuli application and stimuli inhibition.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Sep 20, 2021
From: ACF FINCO I LP
To: LIVANOVA USA, INC.
Reel/Frame 057552/0378 →
SECURITY INTEREST Recorded Aug 16, 2021
From: LIVANOVA USA, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 057188/0001 →
RELEASE OF SECURITY INTEREST Recorded Aug 16, 2021
From: ARES CAPITAL CORPORATION, AS AGENT FOR THE LENDERS
To: LIVANOVA USA, INC.
Reel/Frame 057189/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 30, 2020
From: LIVANOVA USA, INC.
To: ACF FINCO I LP, AS COLLATERAL AGENT
Reel/Frame 054881/0784 →
CHANGE OF NAME Recorded Jun 29, 2020
From: CYBERONICS, INC.
To: LIVANOVA USA, INC.
Reel/Frame 053306/0229 →
PATENT SECURITY AGREEMENT Recorded Jun 17, 2020
From: LIVANOVA USA, INC.
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 053673/0675 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2011
From: LIBBUS, IMAD; AMURTHUR, BADRI; KENKNIGHT, BRUCE H.
To: CYBERONICS, INC.
Reel/Frame 027347/0428 →
Cited By (4)
US 12,280,256 US 12,285,611 US 12,390,645 US 12,558,547